This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Innergex Renewable Energy (OTCPK:INGXF) (TSX:INE) is a Canada-based renewable power producer with a focus on hydroelectric, wind power and solar photovoltaic projects. The company is currently trading at a premium valuation to its peers. Its valuation is supported by its growth potential, long weighted-average PPA duration, and low maintenance expenditure. However, its debt load is quite high and rising benchmark bond yield can impact its share price.
RNW INE AXY NPIFF MGMXF INGXF MGMXD TRSWF TTM AQN NPI
The 2020 Olympic Summer Games are to be held in Tokyo, Japan. The organizers of the games are planning to power the events with 100% renewable energy, which is great news for renewable energy stocks.
BAMGF NAV.PRD TAC TPIC NEE.PRI NAV NEE.PRJ RNW NEE.PRC NEE.PRQ REGI NEE.PRR EVA BAMKF NEE BAM TERP TRSWF BEP
NEW YORK, June 14 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 63.14 points, or 0.39 percent, to 16,328.96. * The biggest contributor to the TSX gain was Enbridge Inc adding 6.9 points to the index. The materials sector was the top sector contributor with a 15.9 point contribution to the upside. * Leading performers in the index were CES Energy Solutions Corp, up 8.5 percent, Yamana Gold Inc, up 5.
ENBBF YRI ACBFF IVN ENB FSM FVI ENB IVPAF ACB RNW AUY BDRPF EBBNF PFSCF TRSWF
CALGARY, Alberta, June 13, 2018 (GLOBE NEWSWIRE) -- TransAlta Renewables Inc. (“TransAlta Renewables” or the “Company”) (TSX:RNW) today announced that it has entered into an agreement with a syndicate of underwriters co-led by CIBC Capital Markets, RBC Capital Markets and Scotiabank, as joint bookrunners, for an offering, on a bought deal basis, of 11,860,000 common shares (“Common Shares”) in the capital of TransAlta Renewables at a price of $12.
RNW TAC TRSWF
In this article, we'll review all utilities in Canada that have increased their dividend for 5 or more years in a row and apply a dividend growth screen to try and find the best high-quality utility companies for further consideration. Turns out there was only one company that passed all of the criteria, but there are still a few other companies that are worthy of your consideration.
ACLTF CNUTF FTS EMRAF RNW VALU FTS TRI BIP CDUAF TRSWF CU
Here's your April 2018 Monthly-Paid (MoPay) Small-Mid-Large Cap Dividend, Yield, Upsides, and Net Gains Reports. Nano-Cap MoPays are not listed.
SCA CCAOF CBL GOOD AD ALARF ORC OXLCO OXLCN SCM GOODM RNW GOODN CJR.B ECC ECCZ AGNC AHOTF DR.DB.A ECCY GOODO GOODP TRSWF DR MFCSF PSEC OXLC ECCB SCQ CJREF ECCA GNL GNL.PRA PBB
Good morning. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to the TransAlta Corporation First Quarter Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [Operator Instructions] Thank you.
RNW TAC TRSWF
Contents: 1. US/CDN Stocks @3.58%+ yield (128) 2. Stocks by price upside (30); 3. Closed-End Investment Companies, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) @6.15%+ yield (62).
FNNCF EBGUF "NHF" GOOD AD ALARF ORC ENDTF GOODM RNW GOODN SOT.UN CJR.B DGS.PR.A AGNC AHOTF GOODO GOODP TRSWF DGS DVSPF CJREF SUNS GNL GNL.PRA
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TSX:RNW / Transalta Renewables Inc on message board site Silicon Investor.